Smoke-Free Nicotine Products Like The IQOS Heat-Not-Burn System

Smoke-Free Nicotine Products Like The IQOS Heat-Not-Burn System



When Philip Morris International (PMI) reacted to the Food and Drug Administration’s (FDA) approval of a modified risk tobacco product marketing order for its proprietary IQOS heat-not-burn product, it heralded it as a broader public health victory.To get more news about Hitaste Hi10, you can visit hitaste.net official website.

The FDA confirmed that IQOS eliminates a traditional cigarette’s burning characteristics by heating the tobacco sticks to a vapor aerosol.

This product is said to significantly reduce the production of harmful and potentially harmful chemicals adding that the company was able to demonstrate that IQOS reduces a human body’s exposure to toxic substances, marking the modification of risk characteristics in the product. It is crucial to note that these sorts of smoke-free nicotine products are not free of risks onto the body, as they still demonstrate modified risks.

“Data submitted by the company shows that marketing these particular products with the authorized information could help addicted adult smokers transition away from combusted cigarettes and reduce their exposure to harmful chemicals, but only if they completely switch,” said Mitch Zeller, director of the FDA’s Center for Tobacco Products.

The FDA hasn’t ruled that IQOS is safer than cigarettes, to reiterate. Note that the order, still, doesn’t mean that IQOS is still a viable means for people to quit smoking and reaching complete nicotine cessation. That said, the IQOS MRTP marketing order is a benchmark case of how the regulatory processes under the Tobacco Control Act work.

Swedish Match AB is the first and only other company to obtain MRTP marketing orders from the FDA for varieties of their snus tobacco and nicotine pouch products. If anything, the process works and still present a favorable outcome for many companies trying to comply with the mandatory PMTA regulations.

Barring the challenges small companies face with PMTA, the opportunity for products to confirm modified risk characteristics is a promising prospect. Electronic cigarettes and vaping devices are still considered a safer alternative to cigarettes by public health groups.

Public Health England, notably, endorses regulated e-cigarettes as 95 percent safer than cigarettes. Food and Drug Administration and the Centers for Disease Control and Prevention scientists note that these products are somewhat safer than cigarettes.